Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

CervoMed (CRVO) EBITDA Margin (2023 - 2025)

Historic EBITDA Margin for CervoMed (CRVO) over the last 9 years, with Q3 2025 value amounting to 2393.3%.

  • CervoMed's EBITDA Margin fell 21556000.0% to 2393.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 417.26%, marking a year-over-year decrease of 2998000.0%. This contributed to the annual value of 166.71% for FY2024, which is 1363200.0% down from last year.
  • CervoMed's EBITDA Margin amounted to 2393.3% in Q3 2025, which was down 21556000.0% from 357.3% recorded in Q2 2025.
  • In the past 5 years, CervoMed's EBITDA Margin registered a high of 140.87% during Q3 2023, and its lowest value of 2393.3% during Q3 2025.
  • For the 3-year period, CervoMed's EBITDA Margin averaged around 352.27%, with its median value being 107.12% (2024).
  • In the last 5 years, CervoMed's EBITDA Margin soared by 118400bps in 2024 and then crashed by -21556000bps in 2025.
  • CervoMed's EBITDA Margin (Quarter) stood at 94.85% in 2023, then tumbled by -230bps to 313.27% in 2024, then tumbled by -664bps to 2393.3% in 2025.
  • Its EBITDA Margin was 2393.3% in Q3 2025, compared to 357.3% in Q2 2025 and 257.06% in Q1 2025.